At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 216 enrolled
Drug / intervention
desflurane +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase 2/3 Clinical Study With BLM-240 in Adult Surgery Patients That Need General Anesthesia
In Brief
A Phase 3 clinical trial evaluating desflurane, desflurane/nitrous oxide, and 1 other intervention for Anesthesia. Completed, enrolled 216 participants across 15 sites.
Detailed Summary
The purposes of this study are to evaluate the efficacy and safety of desflurane (BLM-240) as an anesthetic agent and to demonstrate the non-inferiority of desflurane to sevoflurane in term of awakening/recovery from anesthesia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnesthesia
CountriesJapan
Collaborators--
Timeline
Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2008
Primary CompletionAug 2008
First PostedSep 2008
TodayJul 2026
First PostedSep 30, 2008
Enrollment StartFeb 1, 2008
Primary CompletionAug 1, 2008
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 17.8 years ago
Interventions
desfluranedrug
volatile liquid for inhalation
desflurane/nitrous oxidedrug
volatile liquid for inhalation with gas for inhalation
sevoflurane/nitrous oxidedrug
volatile liquid for inhalation and gas for inhalation